Reliable quantification of the macromolecule signals in short echo-time 1 H MRS spectra is particularly important at high magnetic fields for an accurate quantification of metabolite concentrations (the neurochemical profile) due to effectively increased spectral resolution of the macromolecule components. The purpose of the present study was to assess two approaches of quantification, which take the contribution of macromolecules into account in the quantification step.
Introduction
Localized proton magnetic resonance spectroscopy ( 1 H MRS) became an important tool for investigating brain metabolism non-invasively.
In animal models, 1 H MRS allows the detection of almost 20 metabolites [1] , also called the neurochemical profile: taurine (Tau), creatine (Cr), phosphocreatine (PCr), phosphocholine (PCho), glycerophosphocholine (GPC), glutamate (Glu), glutamine (Gln), myo-inositol (Ins), ascorbate (Asc), alanine (Ala), aspartate (Asp), γ -aminobutyrate (GABA), glutathione (GSH), N-acetylaspartate (NAA), N-acetylaspartylglutamate (NAAG), glucose (Glc), lactate (Lac), phosphoethanolamine (PE) and glycine (Gly). Since brain metabolite concentrations can vary depending on the type of pathology, the usefulness of 1 H MRS has been demonstrated in many brain disorders, e.g., in hepatic encephalopathy; Alzheimer's, Huntington's and Parkinson's diseases; acute traumatic brain injury; cancer; dementia; etc [2, 3] . The metabolite changes help to understand metabolic processes related to the studied pathologies and/or enable to monitor the effect of treatment. At longer echo times (TE above 20 ms), the number of spectral lines, which can be used for quantification, is reduced. As a result, in most in vivo 1 H MRS studies only changes of NAA, Cr+PCr, Cho and Lac have been detected. Short echo-time in vivo 1 H MRS spectra (TE = 1-20 ms) contain more information due to minimal distortions of multiplets of coupled spin systems such as Glu, Gln, Ins, Glc, Asp, Ala, GABA, Asc, PE, Gly and Tau. However, due to overlap of proton signals from brain metabolites, sophisticated approaches for the separation of the metabolite signals are required. Consequently, metabolite concentrations are usually determined by fitting the measured in vivo 1 H MRS spectrum to a linear combination of the spectra of individual metabolites (also called the metabolite basis set). The metabolite basis set can be obtained either by measuring aqueous solutions of pure metabolites or by quantum-mechanical simulations using known spectral parameters [4] . Well-known timeand frequency-domain algorithms [5] [6] [7] [8] , based on metabolite basis sets, are currently used for an accurate quantification. The most frequently used algorithms for proton spectra quantification are QUEST [7] from jMRUI software working in the time domain and LCModel [5, 6] working in the frequency domain.
In addition, the spectra measured at short echo times are further complicated by the presence of macromolecules (broad signals ascribed mainly to cytosolic proteins [9] ), which further complicates the quantification. Reliable quantification of the macromolecule signals in short echo-time proton MRS spectra plays a key role in determining the neurochemical profile [10, 11] . Consequently, an error in the macromolecule estimation can lead to substantial errors in the obtained metabolite concentrations [10, 11] . In addition, it is well known that changes in the macromolecule concentrations can be considered as disease markers [12, 13] .
Modelling the macromolecule contributions in an in vivo spectrum can be done using two main approaches. The macromolecule signal is approximated by a mathematical function and then included in the fit [5, 6, [13] [14] [15] [16] or is separately estimated in a pre-processing step [7, 8, 14, [18] [19] [20] [21] [22] . It is well known that these procedures provide only a mathematical approximation of the real in vivo macromolecule spectra [11, 23] .
This mathematical approach can be satisfactory at low magnetic fields. However, more prior knowledge is needed to obtain an accurate estimation of the metabolite concentrations at higher magnetic fields, where the macromolecule spectrum is better resolved.
In addition to the mathematical approximation of the macromolecules, a second approach was proposed, which provides the necessary prior knowledge. It is based on a separate acquisition of the in vivo macromolecule spectra using an inversion recovery method (a metabolite-nulled spectrum). Then, during the quantification step the in vivo acquired spectrum of macromolecules is either added to the basis set [10, 11, [24] [25] [26] [27] [28] [29] or subtracted from the in vivo signal [23, 30, 31] . Small residuals attributed to metabolites are still observed in the metabolite-nulled spectra due to variability in longitudinal relaxation times of metabolites (T 1 ). Thus, knowledge of the T 1 relaxation times of metabolites is required for identification of these residual metabolite signals and subsequent removal by postprocessing.
The purpose of the present study was to assess the importance of the accurate estimation of the macromolecule contributions in short echo-time proton MRS spectra. Consequently, using LCModel [5, 6] we compared two different approaches of estimating macromolecule contributions in the quantification step at 14.1 T. In the first approach, the spectrum of macromolecules was measured in vivo using the inversion recovery technique and added to the metabolite basis set. In the second approach, the macromolecule spectrum was mathematically approximated using the built-in LCModel spline baseline. Preliminary results of this study have been reported in [32] .
Methods

Animals
In vivo experiments were performed on adult female SpragueDawley rats (five animals, ∼250 g), which were anesthetized during the experiments with 1.5-2.5% isoflurane using a nose mask. Body temperature was maintained at 37.5 ± 1.0
• C by circulating warm water around the animals. All animal experiments were conducted according to federal and local ethical guidelines and the protocols were approved by the local regulatory body.
MRS measurments
Proton spectra were acquired using a Varian Inova (Palo Alto, CA, USA) console interfaced to a 14.1 T magnet (Magnex Scientific, Oxford, UK) with a 26 cm horizontal bore. The magnet was equipped with 12 cm inner-diameter actively shielded gradient sets giving a maximum gradient of 400 mT m −1 in 120 μs. Home-built 14 mm diameter 1 H quadrature surface coils were used as transceivers. Eddy currents were minimized using time-dependent quantitative eddy current field mapping [33] . The static field homogeneity was adjusted by means of first-and second-order shims using an EPI version of FASTMAP [34] . Localized images were obtained in the coronal planes using a multislice fast spin echo protocol with TE/TR = 60/5000 ms, a slice thickness of 1 mm and an in-plane resolution of 94 μm. Spectra were acquired using an ultra-short echo-time spin echo full intensity acquired localization (SPECIAL) technique (TE/TR = 2.8/4000 ms, 4096 complex data points, SW = 7 kHz, 320 averages) [1, 35] . The size of the voxel for 1 H MRS was 3 × 4 × 4 mm 3 including frontal cortex, corpus callosum and striatum. After first-and second-order shimming, the typical linewidth of the water resonance at TE = 2.8 ms was 18-20 Hz. The water signal was suppressed by a series of seven 25 ms asymmetric variable power RF pulses with optimized relaxation delays (VAPOR) [36] . The water suppression pulses were interleaved with three modules of outer volume saturation as described elsewhere [36] . To compensate for the magnetic field drift, spectra were collected in blocks of 16 averages, which were stored separately in the memory and were corrected for the relative shift in frequency. For measuring the in vivo spectrum of macromolecules, the SPECIAL sequence was extended with a 2 ms nonselective hyperbolic secant inversion pulse (a bandwidth of 10 kHz), which was applied at a certain time period (inversion time, TI) before starting the localization part of the sequence, as described in [1] . A series of these inversion recovery spectra (TE of 2.8 ms or 40 ms, TR of 2500 ms and 640 averages) were measured with inversion times of 420, 600, 750, 850 and 1000 ms. Residual signals attributed to incompletely nulled metabolites were removed using HLSVD (Hankel-Lanczos singular value decomposition algorithm) [37] from the jMrui software [38] .
Data analysis
Metabolite concentrations were estimated using the LCModel, combined with a simulated basis set of metabolites and either the spectrum of macromolecules measured in vivo using an inversion recovery technique or the spectrum of macromolecules mathematically approximated using the builtin LCModel spline baseline. The water signal was used as an internal reference and the average relative differences between the concentration estimates using the two approaches were compared. The basis set was created by quantum mechanics simulations, based on the density-matrix formalism [39] , using published values of J-coupling constants and chemical shifts [4] . The Cramér-Rao lower bounds (CRBs) were calculated by LCModel as a measure of the reliability of the metabolite estimates. The metabolite concentrations were estimated for the following 19 neurochemical profiles: Ala, Asp, PCho, Cr, PCr, GABA, Gln, Glu, GSH, Gly, Ins, Lac, NAA, Tau, Asc, Glc, NAAG, GPC and PE.
To evaluate any possible differences between the metabolite concentrations obtained using the two approaches, the metabolite concentrations were statistically compared pairwise using a paired two-tailed Student's t-test. Figure 1 displays the macromolecule spectrum acquired in vivo in the rat brain at 14.1 T. The main resonances of the macromolecules were well identified. However, since T 1 relaxation times of metabolite resonances are not identical [40] , a macromolecule spectrum with completely suppressed metabolite resonances could not be obtained. Consequently, based on the evolution of the metabolite intensities over the series of inversion recovery spectra (changing from negative to positive), the spectrum at TI = 750 ms and TE = 2.8 ms ( figure 1(a) ) was taken as a basis for the spectrum of macromolecules, since it contained the smallest residual metabolite peaks (positive or negative). In addition, the residual metabolite peaks were confirmed by measuring an inversion recovery spectrum with the same TI = 750 ms, Figure 1 . Estimation of the spectrum of macromolecules based on IR-SPECIAL spectra using the TI = 750 ms and TE = 2.8 ms. The spectrum (a) showing minimal residual peaks (negative peaks of NAA at 2 ppm and Tau at 3.4 ppm, and positive peaks of NAA at 2.7 ppm, GPC/PCho at 3.2, Ins at 3.6 ppm and Cr/PCr at 3.9 ppm) was taken as a basis for the spectrum of macromolecules. The spectrum (b) presents the final macromolecule spectrum measured with TI = 750 ms and TE = 40 ms. The spectrum (c) displays the final macromolecule spectrum after removal of the residual metabolite peaks using HLSVD. The residual signal of NAA at 2.7 ppm marked with an asterisk in the spectrum (b) is reduced and inverted relative to the spectrum from (a) due to J-evolution. however, with a longer TE = 40 ms. In this spectrum ( figure 1(b) ) the residual signals of metabolites were visible due to longer T 2 relaxation times, while the signals of macromolecules were substantially reduced due to their short T 2 relaxation times. The residual peaks of NAA at 2.0 and 2.7 ppm, Tau at 3.4 ppm, total choline at 3.2 ppm, Ins at 3.6 ppm and total Cr at 3.9 ppm, identified in the spectrum in figure 1(b) , were then removed from the macromolecule spectrum in figure 1(a) using the HLSVD algorithm. Since the residual peaks were visible in the in vivo spectrum ( figure 1(a) ), they were removed by using the option from the HLSVD algorithm, in which the user defines the frequency region to be removed in the spectrum. The final macromolecule spectrum is displayed in figure 1(c) .
Results and discussion
The LCModel analysis of a representative 14.1 T spectrum is shown in figure 2 . Figure 2 (a) presents the measured in vivo spectrum in the rat brain at 14.1 T. As can be seen, despite excellent spectral dispersion at 14.1 T, many spectral lines of metabolites remained overlapped among each other as well as with macromolecule signals. Figures 2(b) and (c) display the corresponding LCModel fits using the measured macromolecule spectrum ( figure 2(b) ) and the built-in LCModel spline baseline ( figure 2(c) ). The LCModel quantification using a basis set of simulated spectra of metabolites combined with the measured spectrum of the macromolecules provided an excellent fit to the experimental data.
The spectrum fitted without the experimental macromolecule spectrum provided a poor match of the experimental spectrum, with residuals observed particularly in the spectral region from 0.5 to 2.0 ppm, compared to the LCModel fit with the macromolecule spectrum. The fits of the individual metabolites are plotted in figure 2(d) . spectrum combined with the same 14.1 T in vivo spectrum of the rat brain. The built-in LCModel spline baselines obtained from five rats fitted well the signals of macromolecules and they were highly consistent among the animals, except for the region close to H 2 O at around 4.5 ppm ( figure 3(a) ). However, this smooth approximation of the in vivo macromolecules could not reproduce completely all features of the in vivo spectrum of macromolecules at 14.1 T as shown in figure 3(b) . As can be seen in figure 3(a) , compared to the in vivo measured spectrum of macromolecules, the built-in LCModel spline baseline was raised around 2.0 and 4.0 ppm and lowered around 3.0 and 3.2 ppm, leading to a decrease and an increase of concentrations of metabolites resonating in these regions, respectively.
The mean values and standard deviations of the metabolite concentrations obtained using the two approaches are shown in figure 4 . Although there was an overall reasonable agreement in metabolite concentrations, NAA and Glu concentrations were slightly lower (8-15%) and Cr+PCr, GPC+PCho and Gly concentrations were slightly higher (10-17%) when using the fitted splines. A systematic increase of Glc, GABA, PCho, GSH, PE and Asp concentrations (∼30-70%) and a decrease of Ala, Asc, NAAG and Lac concentrations (∼70-100%) were noted when using the fitted splines compared with the approach using measured macromolecules. For almost all metabolites, the standard deviations and CRBs of the metabolite concentrations were similar in the two approaches, except for a few low concentrated metabolites (Ala, Lac, Asc and NAAG), which were higher for the baseline fitted with splines. Statistical significant differences with p values in the range from 0.02 to 0.0001 were obtained for Ala, Asp, GABA, GSH, Lac, NAA, NAAG, Asc, Glc and PE. The metabolite concentrations obtained using the in vivo measured macromolecule spectrum, were in agreement with previous studies [1, 10, 28] . Figure 3 demonstrates that the bias in the metabolite concentrations is due to the raised or lowered baseline fitted with the spline functions.
Only two studies at lower magnetic fields of 3 T and 7 T [11, 23] compared the simulated and experimentally obtained spectra of macromolecules in the quantification of in vivo proton spectra using the Subtract-QUEST algorithm [7] . In this algorithm, the macromolecule spectrum is mathematically estimated from the first data points of the MRS signal. This approach exploits the fact that the macromolecule signals decay rapidly in the time domain due to shorter T 2 relaxation times. Significant differences in the determined concentrations were obtained by the authors when using the mathematical estimation of the macromolecules. These differences are in agreement with our study. Moreover, the authors also observed that the macromolecule spectrum estimated by Subtract-QUEST displayed only broader features, which disagrees with what is actually seen in the measured spectra.
Our results showed that an experimental estimation of the macromolecule spectrum can improve the quality of the fit at 14.1 T. The absence of the measured macromolecule spectrum in the database led to a large and unpredictable bias in the concentrations of many metabolites. Even at the highest magnetic fields available for in vivo experiments, spectral overlap of proton signals from brain metabolites and macromolecules still requires an experimental assessment of macromolecular contribution to the proton spectrum for an accurate metabolite quantification. The main reason for the poor mathematical estimation of macromolecules at high magnetic fields is due to the fact that the largely field-independent linewidth of the signals of macromolecules increasingly approaches that of metabolites. As can also be seen from [1, 10, 11, 41] , an effectively increased spectral resolution of the macromolecule components can be observed at higher magnetic field strengths, making the estimation of the macromolecules by means of mathematical approximations even more difficult.
Conclusion
To our knowledge, this is the first study demonstrating the importance of the accurate assessment of the macromolecule contributions in quantification of short echo-time proton MR spectra using LCModel. Even if the fitted splines reproduce the in vivo macromolecules very well, we can conclude that the measured macromolecular 'baseline' represents additional prior knowledge, which leads to a more accurate and reliable quantification. This kind of knowledge becomes important particularly at higher static magnetic fields.
